Literature DB >> 17325253

Benchmarks for the assessment of novel cardiovascular biomarkers.

David A Morrow, James A de Lemos.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17325253     DOI: 10.1161/CIRCULATIONAHA.106.683110

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  112 in total

1.  Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes: identifying patients who do not respond to standard therapy.

Authors:  Sean P Collins; Christopher J Lindsell; Alan B Storrow; Gregory J Fermann; Phillip D Levy; Peter S Pang; Neal Weintraub; W Frank Peacock; Douglas B Sawyer; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 2.  Early detection of myocardial dysfunction and heart failure.

Authors:  Geoffrey de Couto; Maral Ouzounian; Peter P Liu
Journal:  Nat Rev Cardiol       Date:  2010-05-11       Impact factor: 32.419

3.  Growth differentiation factor 15: a canary in a coal mine?

Authors:  Jennifer E Ho; Thomas J Wang
Journal:  Clin Chem       Date:  2011-11-07       Impact factor: 8.327

4.  Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.

Authors:  Benjamin M Scirica; Marc S Sabatine; Petr Jarolim; Sabina A Murphy; James L de Lemos; Eugene Braunwald; David A Morrow
Journal:  Eur Heart J       Date:  2010-12-22       Impact factor: 29.983

5.  Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.

Authors:  Anand Rohatgi; Parag Patel; Sandeep R Das; Colby R Ayers; Amit Khera; Abelardo Martinez-Rumayor; Jarett D Berry; Darren K McGuire; James A de Lemos
Journal:  Clin Chem       Date:  2011-11-07       Impact factor: 8.327

6.  The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.

Authors:  Bonnie Ky; Benjamin French; Kosha Ruparel; Nancy K Sweitzer; James C Fang; Wayne C Levy; Douglas B Sawyer; Thomas P Cappola
Journal:  J Am Coll Cardiol       Date:  2011-07-19       Impact factor: 24.094

Review 7.  Child health, developmental plasticity, and epigenetic programming.

Authors:  Z Hochberg; R Feil; M Constancia; M Fraga; C Junien; J-C Carel; P Boileau; Y Le Bouc; C L Deal; K Lillycrop; R Scharfmann; A Sheppard; M Skinner; M Szyf; R A Waterland; D J Waxman; E Whitelaw; K Ong; K Albertsson-Wikland
Journal:  Endocr Rev       Date:  2010-10-22       Impact factor: 19.871

8.  Sorting through new biomarkers.

Authors:  Frances O Wood; James A de Lemos
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

Review 9.  The development of gene therapy for diseases of the lung.

Authors:  D R Gill; L A Davies; I A Pringle; S C Hyde
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

10.  Genomics: A gut prediction.

Authors:  Willem M de Vos; Max Nieuwdorp
Journal:  Nature       Date:  2013-05-29       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.